The use of a murine equivalent to CDP7657, consisting of a PEGylated monovalent Fab’ anti-murine CD154 Ab (MR1 Fab’ PEG), for the treatment of NZB/W F1 mice with active lupus induced disease remission [107]. Here, CD40LG is linked to systemic lupus erythematosus.